Hbsag, Anti-Hbs and Anti-Hcv Seroprevalence of the Patients Applied To the Medical Faculty of Bezmialem Foundation University
| dc.authorwosid | Sumbul, Bilge/Mgv-6189-2025 | |
| dc.authorwosid | Doymaz, Mehmet/N-1583-2017 | |
| dc.contributor.author | Iraz, Meryem | |
| dc.contributor.author | Gultepe, Bilge | |
| dc.contributor.author | Doymaz, Mehmet Ziya | |
| dc.date.accessioned | 2025-05-10T17:22:21Z | |
| dc.date.available | 2025-05-10T17:22:21Z | |
| dc.date.issued | 2013 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Iraz, Meryem; Doymaz, Mehmet Ziya] Bezmialem Vakif Univ, Tip Fak, Mikrobiyol Anabilim Dali, Istanbul, Turkey; [Gultepe, Bilge] Yuzuncu Yil Univ, Tip Fak, Mikrobiyol Anabilim Dali, Van, Turkey | en_US |
| dc.description.abstract | Objective: The infections caused by hepatitis B and hepatitis C virus are still remain one of most important health problems for our country. The purpose of this study was to determine the frequency of HBsAg, anti-HBs and anti-HCV positivity in the patients who were admitted to the Research Hospital of the Medical Faculty of Bezmialem Vakif University between November 2011 and May 2013. Materials and Methods: The blood samples were tested for HBsAg, Anti-HBs and anti-HCV by chemiluminescent microparticle immunoassey (CMIA) (Advia Centaur, Siemens, Almanya) Results: In our laboratuary serologically 53.593 patients are tested for HBsAg, 22.300 patients are tested for Anti-HBs and 39.877 patients are tested for Anti-HCV. In our study 5.5%, 42.2% and 1.3% of the patients are found to be seropositive for HBsAg, Anti-HBs and Anti-HCV respectively. Conclusion: The results detected for hepatitis B and hepatitis C virus seropositivity in our region are comparable to those found in other regions of Turkey. | en_US |
| dc.description.woscitationindex | Emerging Sources Citation Index | |
| dc.identifier.doi | 10.4274/Vhd.28199 | |
| dc.identifier.endpage | 109 | en_US |
| dc.identifier.issn | 1307-9441 | |
| dc.identifier.issn | 2147-2939 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.scopusquality | N/A | |
| dc.identifier.startpage | 106 | en_US |
| dc.identifier.uri | https://doi.org/10.4274/Vhd.28199 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/10563 | |
| dc.identifier.volume | 19 | en_US |
| dc.identifier.wos | WOS:000217231800004 | |
| dc.identifier.wosquality | N/A | |
| dc.language.iso | tr | en_US |
| dc.publisher | Galenos Publ House | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Hbsag | en_US |
| dc.subject | Anti-Hbs | en_US |
| dc.subject | Anti-Hcv | en_US |
| dc.subject | Seroprevalance | en_US |
| dc.title | Hbsag, Anti-Hbs and Anti-Hcv Seroprevalence of the Patients Applied To the Medical Faculty of Bezmialem Foundation University | en_US |
| dc.type | Article | en_US |